Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CLOROX CO /DE/CLX · Entity 3474 | EVP - Chief Admin Officer | October 05, 2026 | October 07, 2026 |
| Zovio IncZVO · Entity 124041 | Director | March 29, 2022 | March 31, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CLOROX CO /DE/
Report date October 05, 2026 · Filed October 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 83,591 |
Reported balance
After 2026-10-05 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-10-05 · Grant · Acquired 6,637 · Balance 83,591 F1: Settlement of 2023 Performance Unit Grant, which vested 10/5/26. |
| Common StockSEC Table I · non-derivative | Direct | 81,640 |
Reported balance
After 2026-10-05 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-10-05 · Tax withholding · Disposed 1,951 · Balance 81,640 F2: Withholding of shares by the Company to satisfy tax obligations relating to vesting of performance stock units. |
| Common StockSEC Table I · non-derivative | Direct | 79,498 |
Reported balance
After 2026-10-05 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2026-10-05 · Tax withholding · Disposed 2,142 · Balance 79,498 F3: Withholding of shares by the Company to satisfy tax obligations relating to vesting of restricted stock. F4: Includes 721 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Settlement of 2023 Performance Unit Grant, which vested 10/5/26.
F2: Withholding of shares by the Company to satisfy tax obligations relating to vesting of performance stock units.
F3: Withholding of shares by the Company to satisfy tax obligations relating to vesting of restricted stock.
F4: Includes 721 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan.
Zovio Inc
Report date March 29, 2022 · Filed March 31, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 61,260 |
Reported balance
After 2022-03-29 transaction · row 1
1 source rowRow 1 · 2022-03-29 · Exercise / conversion · Acquired 19,472 · Balance 61,260 F1: On March 29, 2022, 19,472 of the reporting person's restricted stock units were settled for an equal number of shares of the issuer's common stock. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-03-29 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-03-29 · Exercise / conversion · Disposed 3,062 · Balance 0 F2: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F3: Subject to the reporting person's continuing service, the restricted stock units vest as follows: (i) 25% of the restricted stock units vest on the first anniversary of the vesting commencement date, and (ii) an additional 25% of the restricted stock units shall vest on each subsequent anniversary of the vesting commencement date. The vesting commencement date for the restricted stock units is March 29, 2018. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-03-29 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-03-29 · Exercise / conversion · Disposed 16,410 · Balance 0 F2: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F4: Subject to the reporting person's continuing service, 100% of the restricted stock units shall vest on March 29, 2022. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 18,890 |
Reported balance
After 2022-03-29 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-03-29 · Grant · Acquired 18,890 · Balance 18,890 F2: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F5: Subject to the reporting person's continuing service, 100% of the restricted stock units shall vest on March 29, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: On March 29, 2022, 19,472 of the reporting person's restricted stock units were settled for an equal number of shares of the issuer's common stock.
F2: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F3: Subject to the reporting person's continuing service, the restricted stock units vest as follows: (i) 25% of the restricted stock units vest on the first anniversary of the vesting commencement date, and (ii) an additional 25% of the restricted stock units shall vest on each subsequent anniversary of the vesting commencement date. The vesting commencement date for the restricted stock units is March 29, 2018.
F4: Subject to the reporting person's continuing service, 100% of the restricted stock units shall vest on March 29, 2022.
F5: Subject to the reporting person's continuing service, 100% of the restricted stock units shall vest on March 29, 2023.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 05, 2026 Filed Oct 7, 2026 20:24 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Tax withholdingCommon Stock | 2,142 | $80.41 | $172,238.22 |
DisclosureSEC source: 0001225208-26-008312 · doc4.xml · nonDerivative · entry 3 Marriner Kirsten · CIK 0001573187 · EVP - Chief Admin Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,498 F3 · kind: Withholding of shares by the Company to satisfy tax obligations relating to vesting of restricted stock. F4 · balance_after: Includes 721 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan. Read SEC document |
| October 05, 2026 Filed Oct 7, 2026 20:24 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Tax withholdingCommon Stock | 1,951 | $80.41 | $156,879.91 |
DisclosureSEC source: 0001225208-26-008312 · doc4.xml · nonDerivative · entry 2 Marriner Kirsten · CIK 0001573187 · EVP - Chief Admin Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,640 F2 · kind: Withholding of shares by the Company to satisfy tax obligations relating to vesting of performance stock units. Read SEC document |
| October 05, 2026 Filed Oct 7, 2026 20:24 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 6,637 | $80.41 | $533,681.17 |
DisclosureSEC source: 0001225208-26-008312 · doc4.xml · nonDerivative · entry 1 Marriner Kirsten · CIK 0001573187 · EVP - Chief Admin Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,591 F1 · kind: Settlement of 2023 Performance Unit Grant, which vested 10/5/26. Read SEC document |
| September 23, 2026 Filed Sep 25, 2026 21:17 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 12,389 | $83.94 | $1,039,932.66 |
DisclosureSEC source: 0001225208-26-007952 · doc4.xml · nonDerivative · entry 1 Marriner Kirsten · CIK 0001573187 · EVP - Chief Admin Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,683 F1 · kind: The Restricted Stock Units will vest in 4 equal installments - 1/4 on each of October 5, 2027, 2028, 2029, and 2030. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 20:19 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 26,324 | $94.97 | $2,499,990.28 |
DisclosureSEC source: 0001225208-26-006138 · doc4.xml · nonDerivative · entry 1 Marriner Kirsten · CIK 0001573187 · EVP - Chief Admin Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,294 F1 · kind: The Restricted Stock Units will vest in 3 equal installments - 1/3 on each of June 17, 2027, 2028 and 2029. Read SEC document |
| December 12, 2025 Filed Dec 16, 2025 21:36 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Tax withholdingCommon Stock | 310 | $102.83 | $31,877.30 |
DisclosureSEC source: 0001225208-25-010041 · doc4.xml · nonDerivative · entry 1 Marriner Kirsten · CIK 0001573187 · EVP - Chief Admin Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,970 F1 · kind: Withholding of shares by the Company to satisfy employment tax obligations applicable to restricted stock units previously granted to retirement eligible employees. Read SEC document |
| October 03, 2025 Filed Oct 7, 2025 21:10 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Tax withholdingCommon Stock | 3,488 | $122.25 | $426,408.00 |
DisclosureSEC source: 0001225208-25-008530 · doc4.xml · nonDerivative · entry 3 Marriner Kirsten · CIK 0001573187 · EVP - Chief Admin Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,280 F3 · kind: Withholding of shares by the Company to satisfy tax obligations relating to vesting of performance stock units. F4 · balance_after: Includes 534 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan. Read SEC document |
| October 03, 2025 Filed Oct 7, 2025 21:10 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Tax withholdingCommon Stock | 1,653 | $122.25 | $202,079.25 |
DisclosureSEC source: 0001225208-25-008530 · doc4.xml · nonDerivative · entry 2 Marriner Kirsten · CIK 0001573187 · EVP - Chief Admin Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,768 F2 · kind: Withholding of shares by the Company to satisfy tax obligations relating to vesting of restricted stock. Read SEC document |
| October 03, 2025 Filed Oct 7, 2025 21:10 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 9,293 | $122.25 | $1,136,069.25 |
DisclosureSEC source: 0001225208-25-008530 · doc4.xml · nonDerivative · entry 1 Marriner Kirsten · CIK 0001573187 · EVP - Chief Admin Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,421 F1 · kind: Settlement of 2022 Performance Unit Grant that vested 10/3/25. Read SEC document |
| September 16, 2025 Filed Sep 18, 2025 20:21 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 7,689 | $124.85 | $959,971.65 |
DisclosureSEC source: 0001225208-25-008067 · doc4.xml · nonDerivative · entry 1 Marriner Kirsten · CIK 0001573187 · EVP - Chief Admin Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,994 F1 · kind: The Restricted Stock Units will vest in 4 equal installments - 1/4 on each of October 5, 2026, 2027, 2028 and 2029. Read SEC document |
| March 11, 2025 Filed Mar 12, 2025 20:55 UTC | CLOROX CO /DE/ CLX · Entity 3474 | SaleCommon Stock | 733 | $150.00 | $109,950.00 |
DisclosureSEC source: 0001225208-25-003293 · doc4.xml · nonDerivative · entry 5 Marriner Kirsten · CIK 0001573187 · EVP - Chief People Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,305 F1 · kind: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on 12/9/2024, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 20:55 UTC | CLOROX CO /DE/ CLX · Entity 3474 | SaleCommon Stock | 2,832 | $150.85 | $427,207.48 |
DisclosureSEC source: 0001225208-25-003293 · doc4.xml · nonDerivative · entry 4 Marriner Kirsten · CIK 0001573187 · EVP - Chief People Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,038 F1 · kind: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on 12/9/2024, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F5 · price: This transaction was executed in multiple trades at prices ranging from $150.26 to $151.26. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 20:55 UTC | CLOROX CO /DE/ CLX · Entity 3474 | SaleCommon Stock | 2,341 | $151.53 | $354,742.97 |
DisclosureSEC source: 0001225208-25-003293 · doc4.xml · nonDerivative · entry 3 Marriner Kirsten · CIK 0001573187 · EVP - Chief People Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,870 F1 · kind: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on 12/9/2024, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F4 · price: This transaction was executed in multiple trades at prices ranging from $151.275 to $152.045. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 20:55 UTC | CLOROX CO /DE/ CLX · Entity 3474 | SaleCommon Stock | 2,304 | $152.64 | $351,691.78 |
DisclosureSEC source: 0001225208-25-003293 · doc4.xml · nonDerivative · entry 2 Marriner Kirsten · CIK 0001573187 · EVP - Chief People Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,211 F1 · kind: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on 12/9/2024, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F3 · price: This transaction was executed in multiple trades at prices ranging from $152.29 to $153.26. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 20:55 UTC | CLOROX CO /DE/ CLX · Entity 3474 | SaleCommon Stock | 17 | $153.46 | $2,608.83 |
DisclosureSEC source: 0001225208-25-003293 · doc4.xml · nonDerivative · entry 1 Marriner Kirsten · CIK 0001573187 · EVP - Chief People Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 34,515 F1 · kind: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on 12/9/2024, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F2 · price: This transaction was executed in multiple trades at prices ranging from $153.46 to $153.465. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 15, 2024 Filed Nov 18, 2024 23:00 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Tax withholdingCommon Stock | 640 | $167.64 | $107,289.60 |
DisclosureSEC source: 0001225208-24-010044 · doc4.xml · nonDerivative · entry 1 Marriner Kirsten · CIK 0001573187 · EVP - Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,532 F1 · balance_after: Includes 43 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan. Read SEC document |
| October 04, 2024 Filed Oct 8, 2024 20:21 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Tax withholdingCommon Stock | 2,521 | $161.57 | $407,317.97 |
DisclosureSEC source: 0001225208-24-009229 · doc4.xml · nonDerivative · entry 3 Marriner Kirsten · CIK 0001573187 · EVP - Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,172 F3 · kind: Withholding of stock to pay tax liability under the Company's Stock Withholding Arrangement. F4 · balance_after: Includes 227 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan. Read SEC document |
| October 04, 2024 Filed Oct 8, 2024 20:21 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Tax withholdingCommon Stock | 437 | $161.57 | $70,606.09 |
DisclosureSEC source: 0001225208-24-009229 · doc4.xml · nonDerivative · entry 2 Marriner Kirsten · CIK 0001573187 · EVP - Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,693 F2 · kind: Withholding of shares by the Company to satisfy tax obligations applicable to vesting of restricted stock. Read SEC document |
| October 04, 2024 Filed Oct 8, 2024 20:21 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 6,898 | $161.57 | $1,114,509.86 |
DisclosureSEC source: 0001225208-24-009229 · doc4.xml · nonDerivative · entry 1 Marriner Kirsten · CIK 0001573187 · EVP - Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,130 F1 · kind: Settlement of 2021 Performance Unit Grant that vested 10/4/2024. Read SEC document |
| September 17, 2024 Filed Sep 19, 2024 20:40 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 5,221 | $164.69 | $859,846.49 |
DisclosureSEC source: 0001225208-24-008767 · doc4.xml · nonDerivative · entry 1 Marriner Kirsten · CIK 0001573187 · EVP - Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,198 F1 · kind: The Restricted Stock Units will vest in 4 equal installments - 1/4 on each of October 5, 2025, 2026, 2027 and 2028. Read SEC document |
| September 13, 2024 Filed Sep 17, 2024 21:01 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Tax withholdingCommon Stock | 89 | $166.27 | $14,798.03 |
DisclosureSEC source: 0001225208-24-008733 · doc4.xml · nonDerivative · entry 1 Marriner Kirsten · CIK 0001573187 · EVP - Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,977 F1 · kind: Withholding of shares by the Company to satisfy tax obligations applicable to vesting of restricted stock. F2 · balance_after: Includes 33 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan. Read SEC document |
| November 15, 2023 Filed Nov 16, 2023 23:57 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 5,796 | $138.01 | $799,905.96 |
DisclosureSEC source: 0001225208-23-010275 · doc4.xml · nonDerivative · entry 1 Marriner Kirsten · CIK 0001573187 · EVP - Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,033 F1 · kind: The Restricted Stock Units will vest in 4 equal installments - 1/4 on November 15, 2024, and 1/4 on each of October 5, 2025, 2026 and 2027. Read SEC document |
| October 05, 2023 Filed Oct 10, 2023 23:48 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Tax withholdingCommon Stock | 294 | $124.93 | $36,729.42 |
DisclosureSEC source: 0001225208-23-009466 · doc4.xml · nonDerivative · entry 1 Marriner Kirsten · CIK 0001573187 · EVP - Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,237 F1 · kind: Withholding of shares by the Company to satisfy tax obligations applicable to vesting of restricted stock. F2 · balance_after: Includes 37 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan. Read SEC document |
| September 13, 2023 Filed Sep 15, 2023 21:11 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Tax withholdingCommon Stock | 1,036 | $147.35 | $152,654.60 |
DisclosureSEC source: 0001225208-23-008964 · doc4.xml · nonDerivative · entry 3 Marriner Kirsten · CIK 0001573187 · EVP - Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,471 F3 · kind: Withholding of stock to pay tax liability under the Company's Stock Withholding Arrangement. F4 · balance_after: Includes 191 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan. Read SEC document |
| September 13, 2023 Filed Sep 15, 2023 21:11 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Tax withholdingCommon Stock | 101 | $147.35 | $14,882.35 |
DisclosureSEC source: 0001225208-23-008964 · doc4.xml · nonDerivative · entry 2 Marriner Kirsten · CIK 0001573187 · EVP - Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,507 F2 · kind: Withholding of shares by the Company to satisfy tax obligations applicable to vesting of restricted stock. Read SEC document |
| September 13, 2023 Filed Sep 15, 2023 21:11 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 3,156 | $147.35 | $465,036.60 |
DisclosureSEC source: 0001225208-23-008964 · doc4.xml · nonDerivative · entry 1 Marriner Kirsten · CIK 0001573187 · EVP - Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,608 F1 · kind: Settlement of 2020 Performance Unit Grant that vested 9/13/2023. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 20:20 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Tax withholdingCommon Stock | 137 | $131.69 | $18,041.53 |
DisclosureSEC source: 0001225208-22-010906 · doc4.xml · nonDerivative · entry 1 Marriner Kirsten · CIK 0001573187 · EVP - Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,452 F1 · kind: Withholding of stock to pay tax liability under the Company's Stock Withholding Arrangement. F2 · balance_after: Includes 9 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan. Read SEC document |
| September 20, 2022 Filed Sep 22, 2022 21:56 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantStock Option (Right to Buy) · Derivative | 11,127 | $0.00 Strike: $141.30 | $0.00 |
DisclosureSEC source: 0001225208-22-010417 · doc4.xml · derivative · entry 2 Marriner Kirsten · CIK 0001573187 · EVP - Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,127 Underlying: Common Stock · 11,127 shares Expires 2032-09-20 F2 · kind: Option vests in 4 equal installments - 1/4 on each of October 5, 2023, 2024, 2025 and 2026. F2 · derivative.exercise_date: Option vests in 4 equal installments - 1/4 on each of October 5, 2023, 2024, 2025 and 2026. Read SEC document |
| September 20, 2022 Filed Sep 22, 2022 21:56 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 2,123 | $141.30 | $299,979.90 |
DisclosureSEC source: 0001225208-22-010417 · doc4.xml · nonDerivative · entry 1 Marriner Kirsten · CIK 0001573187 · EVP - Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,580 F1 · kind: The Restricted Stock Units will vest in 4 equal installments - 1/4 on each of October 5, 2023, 2024, 2025 and 2026. Read SEC document |
| September 13, 2022 Filed Sep 16, 2022 01:00 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Tax withholdingCommon Stock | 939 | $144.00 | $135,216.00 |
DisclosureSEC source: 0001225208-22-010361 · doc4.xml · nonDerivative · entry 3 Marriner Kirsten · CIK 0001573187 · EVP - Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,457 F3 · kind: Withholding of stock to pay tax liability under the Company's Stock Withholding Arrangement. F4 · balance_after: Includes 176 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan. Read SEC document |
| September 13, 2022 Filed Sep 16, 2022 01:00 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Tax withholdingCommon Stock | 105 | $144.00 | $15,120.00 |
DisclosureSEC source: 0001225208-22-010361 · doc4.xml · nonDerivative · entry 2 Marriner Kirsten · CIK 0001573187 · EVP - Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,396 F2 · kind: Withholding of shares by the Company to satisfy tax obligations applicable to vesting of restricted stock. Read SEC document |
| September 13, 2022 Filed Sep 16, 2022 01:00 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 2,717 | $144.00 | $391,248.00 |
DisclosureSEC source: 0001225208-22-010361 · doc4.xml · nonDerivative · entry 1 Marriner Kirsten · CIK 0001573187 · EVP - Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,501 F1 · kind: Settlement of 2019 Performance Unit Grant that vested 9/13/2022. Read SEC document |
| March 29, 2022 Filed Mar 31, 2022 20:21 UTC | Zovio Inc ZVO · Entity 124041 | GrantRestricted Stock Unit · Derivative | 18,890 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-007793 · doc1.xml · derivative · entry 4 Marriner Kirsten · CIK 0001573187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,890 Underlying: Common Stock · 18,890 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F5 · derivative.exercise_date: Subject to the reporting person's continuing service, 100% of the restricted stock units shall vest on March 29, 2023. F5 · derivative.expiration_date: Subject to the reporting person's continuing service, 100% of the restricted stock units shall vest on March 29, 2023. Read SEC document |
| March 29, 2022 Filed Mar 31, 2022 20:21 UTC | Zovio Inc ZVO · Entity 124041 | Exercise / conversionRestricted Stock Unit · Derivative | 16,410 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-007793 · doc1.xml · derivative · entry 3 Marriner Kirsten · CIK 0001573187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,410 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F4 · derivative.exercise_date: Subject to the reporting person's continuing service, 100% of the restricted stock units shall vest on March 29, 2022. F4 · derivative.expiration_date: Subject to the reporting person's continuing service, 100% of the restricted stock units shall vest on March 29, 2022. Read SEC document |
| March 29, 2022 Filed Mar 31, 2022 20:21 UTC | Zovio Inc ZVO · Entity 124041 | Exercise / conversionRestricted Stock Unit · Derivative | 3,062 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-007793 · doc1.xml · derivative · entry 2 Marriner Kirsten · CIK 0001573187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,062 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F3 · derivative.exercise_date: Subject to the reporting person's continuing service, the restricted stock units vest as follows: (i) 25% of the restricted stock units vest on the first anniversary of the vesting commencement date, and (ii) an additional 25% of the restricted stock units shall vest on each subsequent anniversary of the vesting commencement date. The vesting commencement date for the restricted stock units is March 29, 2018. F3 · derivative.expiration_date: Subject to the reporting person's continuing service, the restricted stock units vest as follows: (i) 25% of the restricted stock units vest on the first anniversary of the vesting commencement date, and (ii) an additional 25% of the restricted stock units shall vest on each subsequent anniversary of the vesting commencement date. The vesting commencement date for the restricted stock units is March 29, 2018. Read SEC document |
| March 29, 2022 Filed Mar 31, 2022 20:21 UTC | Zovio Inc ZVO · Entity 124041 | Exercise / conversionCommon Stock | 19,472 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-007793 · doc1.xml · nonDerivative · entry 1 Marriner Kirsten · CIK 0001573187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,260 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On March 29, 2022, 19,472 of the reporting person's restricted stock units were settled for an equal number of shares of the issuer's common stock. Read SEC document |
| September 22, 2021 Filed Sep 23, 2021 23:22 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Tax withholdingCommon Stock | 98 | $162.19 | $15,894.62 |
DisclosureSEC source: 0001225208-21-012523 · doc4.xml · nonDerivative · entry 2 Marriner Kirsten · CIK 0001573187 · EVP - Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,608 F2 · kind: Withholding of shares by the Company to satisfy tax obligations applicable to vesting of restricted stock. F3 · balance_after: Includes 4 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan. Read SEC document |
| September 21, 2021 Filed Sep 23, 2021 23:22 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantStock Option (Right to Buy) · Derivative | 11,673 | $0.00 Strike: $163.77 | $0.00 |
DisclosureSEC source: 0001225208-21-012523 · doc4.xml · derivative · entry 4 Marriner Kirsten · CIK 0001573187 · EVP - Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,673 Underlying: Common Stock · 11,673 shares Expires 2031-09-21 F4 · kind: Option vests in 4 equal installments on each of October 5 of 2022, 2023, 2024 and 2025. F4 · derivative.exercise_date: Option vests in 4 equal installments on each of October 5 of 2022, 2023, 2024 and 2025. Read SEC document |
| September 21, 2021 Filed Sep 23, 2021 23:22 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 1,587 | $163.77 | $259,902.99 |
DisclosureSEC source: 0001225208-21-012523 · doc4.xml · nonDerivative · entry 1 Marriner Kirsten · CIK 0001573187 · EVP - Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,702 F1 · kind: The Restricted Stock Units will vest in 4 equal installments on each of October 5 of 2022, 2023, 2024 and 2025. Read SEC document |
| August 19, 2021 Filed Aug 23, 2021 23:31 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Tax withholdingCommon Stock | 911 | $171.10 | $155,872.10 |
DisclosureSEC source: 0001225208-21-011664 · doc4.xml · nonDerivative · entry 2 Marriner Kirsten · CIK 0001573187 · EVP - Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,115 F2 · kind: Withholding of stock to pay tax liability under the Company's Stock Withholding Arrangement. F3 · balance_after: Includes 127 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan. Read SEC document |
| August 19, 2021 Filed Aug 23, 2021 23:31 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 2,632 | $171.10 | $450,335.20 |
DisclosureSEC source: 0001225208-21-011664 · doc4.xml · nonDerivative · entry 1 Marriner Kirsten · CIK 0001573187 · EVP - Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,026 F1 · kind: Settlement of 2018 Performance Unit Grant that vested 8/19/2020. Read SEC document |
| March 29, 2021 Filed Mar 31, 2021 19:39 UTC | Zovio Inc ZVO · Entity 124041 | GrantRestricted Stock Unit · Derivative | 16,410 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-007331 · doc1.xml · derivative · entry 4 Marriner Kirsten · CIK 0001573187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,410 Underlying: Common Stock · 16,410 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F5 · derivative.exercise_date: Subject to the reporting person's continuing service, 100% of the restricted stock units shall vest on March 29, 2022. F5 · derivative.expiration_date: Subject to the reporting person's continuing service, 100% of the restricted stock units shall vest on March 29, 2022. Read SEC document |
| March 29, 2021 Filed Mar 31, 2021 19:39 UTC | Zovio Inc ZVO · Entity 124041 | Exercise / conversionRestricted Stock Unit · Derivative | 18,890 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-007331 · doc1.xml · derivative · entry 3 Marriner Kirsten · CIK 0001573187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,890 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F4 · derivative.exercise_date: Subject to the reporting person's continuing service, 100% of the restricted stock units shall vest on March 29, 2021. F4 · derivative.expiration_date: Subject to the reporting person's continuing service, 100% of the restricted stock units shall vest on March 29, 2021. Read SEC document |
| March 29, 2021 Filed Mar 31, 2021 19:39 UTC | Zovio Inc ZVO · Entity 124041 | Exercise / conversionRestricted Stock Unit · Derivative | 3,062 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-007331 · doc1.xml · derivative · entry 2 Marriner Kirsten · CIK 0001573187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,062 Underlying: Common Stock · 3,062 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F3 · derivative.exercise_date: Subject to the reporting person's continuing service, the restricted stock units vest as follows: (i) 25% of the restricted stock units vest on the first anniversary of the vesting commencement date, and (ii) an additional 25% of the restricted stock units shall vest on each subsequent anniversary of the vesting commencement date. The vesting commencement date for the restricted stock units is March 29, 2018. F3 · derivative.expiration_date: Subject to the reporting person's continuing service, the restricted stock units vest as follows: (i) 25% of the restricted stock units vest on the first anniversary of the vesting commencement date, and (ii) an additional 25% of the restricted stock units shall vest on each subsequent anniversary of the vesting commencement date. The vesting commencement date for the restricted stock units is March 29, 2018. Read SEC document |
| March 29, 2021 Filed Mar 31, 2021 19:39 UTC | Zovio Inc ZVO · Entity 124041 | Exercise / conversionCommon Stock | 21,952 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-007331 · doc1.xml · nonDerivative · entry 1 Marriner Kirsten · CIK 0001573187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,788 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On March 29, 2021, 21,952 of the reporting person's restricted stock units were settled for an equal number of shares of the issuer's common stock. Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 22:04 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionStock Option (Right to Buy) · Derivative | 24,560 | $0.00 Strike: $123.09 | $0.00 |
DisclosureSEC source: 0001225208-20-013738 · doc4.xml · derivative · entry 7 Marriner Kirsten · CIK 0001573187 · EVP - Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,560 shares Expires 2026-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 22:04 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionStock Option (Right to Buy) · Derivative | 18,427 | $0.00 Strike: $135.57 | $0.00 |
DisclosureSEC source: 0001225208-20-013738 · doc4.xml · derivative · entry 6 Marriner Kirsten · CIK 0001573187 · EVP - Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,143 Underlying: Common Stock · 18,427 shares Expires 2027-09-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 22:04 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionStock Option (Right to Buy) · Derivative | 22,380 | $0.00 Strike: $125.94 | $0.00 |
DisclosureSEC source: 0001225208-20-013738 · doc4.xml · derivative · entry 5 Marriner Kirsten · CIK 0001573187 · EVP - Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,380 shares Expires 2026-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 22:04 UTC | CLOROX CO /DE/ CLX · Entity 3474 | SaleCommon Stock | 62,206 | $210.00 | $13,063,260.00 |
DisclosureSEC source: 0001225208-20-013738 · doc4.xml · nonDerivative · entry 4 Marriner Kirsten · CIK 0001573187 · EVP - Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,267 F1 · kind: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on August 19, 2020, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed. Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 22:04 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionCommon Stock | 18,427 | $135.57 | $2,498,148.39 |
DisclosureSEC source: 0001225208-20-013738 · doc4.xml · nonDerivative · entry 3 Marriner Kirsten · CIK 0001573187 · EVP - Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,473 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on August 19, 2020, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.